Home RxNorm 2722661 mNEXSPIKE 2025-2026 vaccine, 0.2 ML Prefilled Syringe Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 2722661
RxNorm name mNEXSPIKE 2025-2026 vaccine, 0.2 ML Prefilled Syringe
Display name mNEXSPIKE 2025-2026 vaccine, 0.2 ML Prefilled Syringe
Full name mNEXSPIKE 2025-2026 vaccine, 0.2 ML Prefilled Syringe
Term type PSN
Status DailyMed mapping
Updated 2026-06-04 23:39:09 Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 125835 mnexspike COVID-19 Vaccine, mRNA 351(a) Rx 2026-07-01
RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.
No records found.
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
DailyMed RxNorm Mappings# unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.
Set ID, RxNorm mappings, Terms table Set ID RxNorm mappings Terms SPL version Label Effective 97c27eb6-1d2e-4953-afac-882ada70c6f8 mNEXSPIKE 2025-2026 vaccine, 0.2 ML Prefilled Syringe [PSN] · 0.2 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 OMICRON (LP.8.1) 0.05 MG/ML Prefilled Syringe [Mnexspike 2025-2026] [SBD] · 0.2 ML Mnexspike 2025-2026 0.05 MG/ML Prefilled Syringe [SY] · mNEXSPIKE 2025-2026 vaccine, 0.2 ML Prefilled Syringe [SY] 4 1 These highlights do not include all the information needed to use MNEXSPIKE safely and effectively. See full prescribing information for MNEXSPIKE . MNEXSPIKE (COVID-19 Vaccine, mRNA) injectable suspension, for intramuscular use 2025-2026 Formula Initial U.S. Approval: 2025 20250827